Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis

Cell Proliferation

Volumn 45, Issue 6, 2012, Pages 487-498

  Ouyang, L ^a   Shi, Z ^b,c   Zhao, S ^b   Wang, F T ^a,b   Zhou, T T ^d   Liu, B ^a   Bao, J K ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c GUIZHOU NORMAL UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; B RAF KINASE; BECLIN 1; CYTOCHROME C; CYTOKINE; DEATH RECEPTOR 4; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOCHONDRIAL ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NECROSTATIN 1; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLASMA MEMBRANE DEATH RECEPTOR; PROCASPASE 3; PROCASPASE 8; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; PROTEIN P62; RAF PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL SURVIVAL; DNA DAMAGE; DRUG TARGETING; ENZYME ACTIVATION; HUMAN; LEUKEMIA; MELANOMA; MITOCHONDRIAL PERMEABILITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NECROPTOSIS; NEOPLASM; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; SIGNAL TRANSDUCTION;

HARNESS;

EID: 84868197448     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00845.x     Document Type: Article

References (116)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
2. Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, Mendes P et al. (2009) A systems biology view of cancer. Biochim. Biophys. Acta 1796, 129-139.
3. Tan ML, Ooi JP, Ismail N, Moad AI, Muhammad TS (2009) Programmed cell death pathways and current antitumor targets. Pharmacol. Res. 26, 1547-1560.
4. Bialik S, Zalckvar E, Ber Y, Rubinstein AD, Kimchi A (2010) Systems biology analysis of programmed cell death. Trends Biochem. Sci. 35, 556-564.
5. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
6. Nishida K, Yamaguchi O, Otsu K (2008) Crosstalk between autophagy and apoptosis in heart disease. Circ. Res. 103, 343-351.
7. Martin SJ, Green DR (1995) Protease activation during apoptosis: death by a thousand cuts? Cell 82, 349-352.
8. Cohen GM, Sun XM, Fearnhead H, MacFarlane M, Brown DG, Snowden RT et al. (1994) Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J. Immunol. 153, 507-516.
9. Liu JJ, Lin M, Yu JY, Liu B, Bao JK (2011) Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett. 300, 105-114.
10. Huett A, Goel G, Xavier RJ (2010) A systems biology viewpoint on autophagy in health and disease. Curr. Opin. Gastroenterol. 26, 302-309.
11. Chen S, Rehman SK, Zhang W, Wen A, Yao L, Zhang J (2010) Autophagy is a therapeutic target in anticancer drug resistance. Biochim. Biophys. Acta 1806, 220-229.
12. Li ZY, Yang Y, Ming M, Liu B (2011) Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun. 414, 5-8.
13. He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67-93.
14. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 16, 966-975.
15. Liu B, Cheng Y, Liu Q, Bao JK, Yang JM (2010) Autophagic pathways as new targets for cancer drug development. Acta Pharmacol. Sin. 31, 1154-1164.
16. Wu W, Liu P, Li J (2012) Necroptosis: an emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 82, 249-258.
17. McCall K (2010) Genetic control of necrosis - another type of programmed cell death. Curr. Opin. Cell Biol. 22, 882-888.
18. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589-598.
19. Amelio I, Melino G, Knight RA (2011) Cell death pathology: cross-talk with autophagy and its clinical implications. Biochem. Biophys. Res. Commun. 414, 277-281.
20. Eum KH, Lee M (2011) Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts. Mol. Cell. Biochem. 348, 61-68.
21. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. Cancer J. Clin. 55, 178-194.
22. Wang SY, Yu QJ, Zhang RD, Liu B (2011) Core signaling pathways of survival/death in autophagy-related cancer networks. Int. J. Biochem. Cell Biol. 43, 1263-1266.
23. White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer. 12, 401-410.
24. Kundu M, Thompson CB (2008) Autophagy: basic principles and relevance to disease. Annu. Rev. Pathol. 3, 427-455.
25. Galluzzi L, Kroemer G (2008) Necroptosis: a specialized pathway of programmed necrosis. Cell 135, 1161-1163.
26. Golstein P, Kroemer G (2007) Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32, 37-43.
27. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18, 1272-1282.
28. Agostinis P, Buytaert E, Breyssens H, Hendrickx N (2004) Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3, 721-729.
29. Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquere S et al. (2005) The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 118, 3091-3102.
30. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112-119.
31. Han W, Xie J, Li L, Liu Z, Hu X (2009) Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 14, 674-686.
32. Liu P, Xu B, Shen W, Zhu H, Wu W, Fu Y et al. (2012) Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic: suppression of CYLD gene by LEF1. Leukemia. 26, 1293-1300.
33. Sayers TJ (2011) Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol. Immunother. 60, 1173-1180.
34. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, Miao QX et al. (1999) Fas-induced caspase denitrosylation. Science 284, 651-654.
35. Sun SY (2011) Understanding the role of the death receptor 5/FADD/caspase-8 death signaling in cancer metastasis. Mol. Cell. Pharmacol. 3, 31-34.
36. Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA et al. (2008) FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc. Natl. Acad. Sci. USA 105, 16677-16682.
37. Llambi F, Green DR (2011) Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr. Opin. Genet. Dev. 21, 12-20.
38. Engel T, Henshall DC (2009) Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? IJPPP 1, 97-115.
39. Shamas-Din A, Brahmbhatt H, Leber B, Andrews DW (2011) BH3-only proteins: orchestrators of apoptosis. Biochim. Biophys. Acta 1813, 508-520.
40. Wen X, Lin ZQ, Liu B, Wei YQ (2012) Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer. Cell Prolif. 45, 217-224.
41. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
42. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
43. Kelly PN, Strasser A (2011) The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 18, 1414-1424.
44. Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M et al. (2009) Caspase genes apoptosis and cancer: mutations within caspase genes. Am. J. Med. Genet. 46, 497-510.
45. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687.
46. Chen M, Wang J (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7, 313-319.
47. Kurokawa M, Kornbluth S (2009) Caspases and kinases in a death grip. Cell 138, 838-854.
48. Giansanti V, Torriglia A, Scovassi AI (2011) Conversation between apoptosis and autophagy: "Is it your turn or mine?". Apoptosis 16, 321-333.
49. Allan LA, Clarke PR (2009) Apoptosis and autophagy: regulation of caspase-9 by Phosphorylation. FEBS J. 276, 6063-6073.
50. Bratton SB, Walker G, Srinivasula SM, Sun XM, Butterworth M, Alnemri ES et al. (2001) Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 20, 998-1009.
51. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H et al. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9. Cell 94, 325-337.
52. Martin MC, Allan LA, Lickrish M, Sampson C, Morrice N, Clarke PR (2005) Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c. J. Biol. Chem. 280, 15449-15455.
53. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759.
54. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE et al. (2004) Oscillations in NF-κB signaling control the dynamics of gene expression. Science 306, 704-708.
55. Kühnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M et al. (2000) NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J. Biol. Chem. 275, 6421-6427.
56. Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3, 17-26.
57. Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I (kappa) Bkinase-beta. Nature 396, 77-80.
58. Song JK, Jo MR, Park MH, Song HS, An BJ, Song MJ et al. (2012) Cell growth inhibition and induction of apoptosis by snake venom toxin in ovarian cancer cell via inactivation of nuclear factor kappaB and signal transducer and activator of transcription 3. Arch. Pharm. Res. 35, 867-876.
59. Ling H, Zhang Y, Ng KY, Chew EH (2011) Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res. Treat. 126, 609-620.
60. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
61. Benchimol S (2001) P53-dependent pathways of apoptosis. Cell Death Differ. 8, 1049-1051.
62. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 100, 1931-1936.
63. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, Vasconcelos MH (2011) MicroRNA regulation of core apoptosis pathways in cancer. Eur. J. Cancer 47, 163-174.
64. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in cancer. Annu. Rev. Med. 60, 167-179.
65. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL et al. (2008) MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J. Biol. Chem. 283, 29897-29903.
66. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR (2010) Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84, 11670-11678.
67. Wang Y, Lee CG (2009) MicroRNA and cancer - focus on apoptosis. J. Cell Mol. Med. 13, 12-23.
68. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714.
69. Tsang WP, Kwok TT (2008) Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13, 1215-1222.
70. Esau CC, Monia BP (2007) Therapeutic potential for microRNAs. Adv. Drug Deliver. Rev. 59, 101-114.
71. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y (2000) Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150, 1507-1513.
72. Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL et al. (2008) FIP200, a uLK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell Biol. 181, 497-510.
73. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y et al. (2009) Nutrient-dependent mTORC1 association with the uLK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 7, 1981-1991.
74. White E, DiPaola RS (2009) The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res. 15, 5308-5316.
75. Weinstein IB (2002) Addiction to oncogenes - the Achilles heal of cancer. Science 297, 63-64.
76. Weinstein IB, Joe AK (2006) Mechanisms of disease: oncogene addiction - a rationale for molecular targeting in cancer therapy. Nat. Clin. Pract. Oncol. 3, 448-457.
77. Yap MD, Garrett MD, Walton MI, Raynaud F, de Bono JS, Workman P (2008) Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr. Opin. Pharmacol. 8, 393-412.
78. Crabbe T, Welham MJ, Ward SG (2007) The PI3K inhibitor arsenal: choose your weapon!. Trends Biochem. Sci. 32, 450-456.
79. Staal SP (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. USA 84, 5034-5037.
80. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D et al. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468.
81. Zhang BH, Guan KL (2000) Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19, 5429-5439.
82. Akca H, Demiray A, Aslan M, Acikbas I, Tokgun O (2012) tumour suppressor PTEN enhanced enzyme activity of GPx, SOD and catalase by suppression of PI3K/AKT pathway in non-small cell lung cancer cell lines. J. Enzyme Inhib. Med. Chem., doi: 10.3109/14756366.2011.654114.
83. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E et al. (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18, 2893-2904.
84. Lee JTJ, McCubrey JA (2002) Targeting the Raf kinase cascade in cancer therapy-novel molecular targets and therapeutic strategies. Expert Opin. Ther. Tar. 6, 659-678.
85. Rojas AM, Fuentes G, Rausell A, Valencia A (2012) The Ras protein superfamily: evolutionary tree and role of conserved amino acids. J. Cell Biol. 196, 189-201.
86. Jin Y, Shima Y, Furu M, Aoyama T, Nakamata T, Nakayama T et al. (2010) Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. Anticancer Res. 30, 245-251.
87. Cantrell DA (2003) GTPases and T cell activation. Immunol. Rev. 192, 122-130.
88. Marais R, Light Y, Paterson HF, Marshall CJ (1995) Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14, 3136-3145.
89. Schlesinger TK, Fanger GR, Yujiri T, Johnson GL (1998) The TAO of MEKK. Front. Biosci. 3, 1181-1186.
90. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121-134.
91. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16, 3-11.
92. Duran A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP et al. (2004) The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6, 303-309.
93. Budanov AV, Karin M (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460.
94. Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, Mouchel PL et al. (2009) Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8, 1571-1576.
95. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M et al. (2008) Regulation of autophagy by cytoplasmic p53. Nat. Chem. Biol. 10, 676-687.
96. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694.
97. Zhang X, Rielland M, Yalcin S, Ghaffari S (2011) Regulation and function of FoxO transcription factors in normal and cancer stem cells: what have we learned? Curr. Drug Targets 12, 1267-1283.
98. Jiang Q, Wang Y, Li T, Shi K, Li Z, Ma Y et al. (2011) Heat shock protein 90-mediated inactivation of nuclear factor-kappaB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells. Mol. Biol. Cell 22, 1167-1180.
99. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G et al. (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64.
100. Qing G, Yan P, Qu Z, Liu H, Li H, Xiao G (2007) Hsp90 regulates processing of NF-kB2 p100 involving protection of NF-kB-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res. 17, 520-530.
101. Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C, Souquere S (2006) NF-kB activation represses TNF a-induced autophagy. J. Biol. Chem. 281, 30373-30382.
102. Fu LL, Wen X, Bao JK, Liu B (2012) MicroRNA-modulated autophagic signaling networks in cancer. Int. J. Biochem. Cell Biol. 44, 733-736.
103. Stack JH, DeWald DB, Takegawa K, Emr SD (1995) Vesicle-mediated protein transport: regulatory interactions between the Vps15 protein kinase and the Vps34 PtdIns 3-kinase essential for protein sorting to the vacuole in yeast. J. Cell Biol. 129, 321-334.
104. Kihara A, Noda T, Ishihara N, Ohsumi Y (2001) Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152, 519-530.
105. Furuya N, Yu J, Byfield M, Pattingre S, Levine B (2005) The evolutionarily conserved domain of Beclin-1 is required for Vps34 binding, autophagy and tumor-suppressor function. Autophagy 1, 46-52.
106. Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH et al. (2006) Autophagic and tumour suppressor activity of a novel Beclin-1-binding protein UVRAG. Nat. Cell Biol. 8, 688-699.
107. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y et al. (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat. Cell Biol. 9, 1142-1151.
108. He C, Levine B (2010) The Beclin 1 interactome. Curr. Opin. Cell Biol. 22, 140-149.
109. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC et al. (2009) Anti- and pro-tumor functions of autophagy. Biochem. Biophys. Acta 1793, 1524-1532.
110. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC et al. (2009) RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332-336.
111. Moubarak RS, Yuste VJ, Artus C, Bouharrour A, Greer PA, Menissier-de Murcia J et al. (2007) Sequential activation of poly (ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol. Cell. Biol. 27, 4844-4862.
112. Xu Y, Huang S, Liu ZG, Han J (2006) Poly (ADP-ribose) polymer-ase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J. Biol. Chem. 281, 8788-8795.
113. Hassa PO (2009) The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survival. Front. Biosci. 14, 72-111.
114. Kim YS, Morgan MJ, Choksi S, Liu ZG (2007) TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell 26, 675-687.
115. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M et al. (2009) Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123.
116. He S, Wang L, Miao L, Wang T, Du F, Zhao L et al. (2009) Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137, 1100-1111.